SAN CARLOS: 1008 Laurel StreetSAN MATEO: 88 N. San Mateo Drive650-342-9449

Tinnitus Research

Pulsatile Tinnitus and the First U.S. Stent Trial: What BosSTENT Means for Patients

If your tinnitus beats in time with your pulse, it is a different problem from ordinary ringing. On October 2, 2026, the FDA approved an Investigational Device Exemption for B-SILENT 2, a U.S. pivotal trial of the BosSTENT, a stent designed for the veins that drain blood from the brain. Sonorous Neurovascular, the maker, says U.S. enrollment is expected to begin in the fourth quarter of 2026.

Tinnitus Research

The stent is investigational. It is not approved, and no clinic can offer it outside a trial. What matters for most readers is the lesson underneath the news: pulsatile tinnitus deserves a medical workup first, because it can point to a vascular cause that a hearing aid or sound therapy does not treat.

At California Hearing Center we test hearing and treat ordinary tinnitus. We do not offer or refer for this stent. If your tinnitus pulses, start with the page on pulsatile tinnitus.

At a glance

  • The FDA approved an IDE on October 2, 2026 for B-SILENT 2, a U.S. pivotal trial of the BosSTENT for pulsatile tinnitus caused by venous sinus stenosis, per Sonorous.
  • U.S. enrollment is expected in Q4 2026, per the company. The device is investigational and not approved.
  • Venous sinus stenosis is a narrowing of a brain vein. The company calls it the most common cause of pulsatile tinnitus. A workup, not a guess, establishes the cause in any one person.
  • Pulsatile tinnitus needs a medical evaluation first. Lenire and other tinnitus sound therapies are not for pulsatile tinnitus.
  • Ordinary ringing is a different story, and the 2026 sound therapy trial is relevant there.

What happened

Sonorous Neurovascular announced on October 2, 2026 that the FDA approved its IDE application for B-SILENT 2, which the company calls the first FDA-approved IDE trial of a venous sinus stent for pulsatile tinnitus. It follows an FDA Breakthrough Device Designation for BosSTENT in February 2026. A separate study, B-SILENT, is enrolling at sites in France and Canada to support a European CE Mark. A Breakthrough designation and a trial approval are steps toward review. They do not mean the device works or is cleared for sale.

What pulsatile tinnitus is

Most tinnitus is a steady ring, buzz or hiss. Pulsatile tinnitus is a whooshing or thumping that beats with your heartbeat. It often comes from blood flow near the ear rather than from the hearing system. One cause is venous sinus stenosis, a narrowing in one of the large veins that drain blood from the brain. Sonorous calls it the most common cause of pulsatile tinnitus. Other causes exist, including conditions of the arteries, so the cause in any one person has to be found by a doctor.

What a stent trial tests

A stent is a small mesh tube that holds a narrowed vein open. B-SILENT 2 will test whether the BosSTENT is safe and effective for people whose pulsatile tinnitus comes from symptomatic venous sinus stenosis. It is a procedure with risks, done by specialists, and a trial will tell us more. Until then, nobody can say how well it works. Do not read this page as a recommendation for or against any procedure.

Numbered list: pulsatile tinnitus beats with your pulse; BosSTENT is in a U.S. trial; it is not approved; a workup comes first; Lenire is not for pulsatile tinnitus.
Details from Sonorous Neurovascular's October 2026 release.

Why a medical workup comes first

Pulsatile tinnitus can signal a blood vessel problem. Sudden onset, one-sided tinnitus, dizziness, headaches or vision changes make a prompt medical review more important. Doctors may order imaging to look at the veins and arteries. Read our page on when to see a doctor about tinnitus for the warning signs. A hearing test is still useful, because it shows how your hearing is and helps the doctor.

Signs your tinnitus needs a doctor first

If any of these apply, do not wait.

  1. The sound beats in time with your heartbeat.
  2. It started suddenly or only in one ear.
  3. You also have dizziness, headaches or vision changes.
  4. It is getting louder over days or weeks.

Take the free 3-minute hearing check

Where sound therapy fits, and where it does not

Sound therapy and amplification are for ordinary, non-pulsatile tinnitus. A 2026 trial in France found that hearing-aid sound therapy reduced tinnitus distress in people with mild hearing loss. Read about it in our page on the sound therapy trial. Lenire, a tinnitus device we offer, is not for pulsatile tinnitus. See tinnitus therapy at California Hearing Center and our Lenire page. Pulsatile tinnitus gets a medical workup first.

Two kinds of tinnitus, and what each needs first
Ordinary tinnitusPulsatile tinnitus
What you hearRinging, buzzing or hissingA whoosh or thump that beats with your pulse
Usual first stepHearing evaluation and a tinnitus planMedical workup, often with imaging
Sound therapy and hearing aidsMay help. A 2026 trial showed benefit with mild hearing lossNot the treatment for the cause
LenireA candidacy visit decidesNot for pulsatile tinnitus
BosSTENTNot relevantInvestigational. In a U.S. pivotal trial, enrollment expected Q4 2026
BosSTENT details from Sonorous Neurovascular's October 2026 release. The device is not approved.

A note for patients

If you hear your heartbeat in your ear, do not wait it out and do not self-treat. A medical workup comes first. A hearing evaluation can sit alongside it and give your doctor useful information. And if your tinnitus is the ordinary kind, there is real help to talk about.

What to do next

Book a comprehensive hearing evaluation at our San Mateo office or our San Carlos office, or call 650-342-9449. Tell us if your tinnitus pulses, so we can point you to the right medical review.

Last updated and sources

Last updated October 28, 2026. What changed: this is the first version. We will update the page when Sonorous reports that U.S. enrollment has begun. Sources: Sonorous Neurovascular release via PR Newswire, October 2026, Hearing Health Matters, October 11, 2026, Endovascular Today, October 9, 2026.

Medical information notice

This page offers general information about a clinical trial. It is not medical advice, and it does not diagnose or recommend any procedure. The BosSTENT is investigational and not approved. Pulsatile tinnitus needs a medical evaluation. Call 650-342-9449 to book at our San Mateo office, 88 N. San Mateo Drive, or our San Carlos office, 1008 Laurel Street.

Pulsatile tinnitusBosSTENT is investigationalIDE approved Oct 2, 2026Medical workup firstLenire not for pulsatileOrdinary tinnitus differs

Get one email when U.S. enrollment in this trial begins.

We will write once when there is news on the B-SILENT 2 trial. We will send nothing else.

We use your email only to send this update. No health information.

Frequently asked questions

A few questions worth asking

Is the BosSTENT approved?

No. It is investigational. The FDA approved an IDE so the company can run the U.S. B-SILENT 2 trial, and it has a Breakthrough Device Designation. Neither is approval for sale.

Can I get a stent for pulsatile tinnitus now?

Not as an approved treatment with this device. Venous sinus stenting is a specialist decision made after a workup, and the BosSTENT is available only in studies. California Hearing Center does not offer or refer for it.

Does my tinnitus come from venous sinus stenosis?

Possibly, if it pulses, but only a medical workup can say. Sonorous calls stenosis the most common cause of pulsatile tinnitus, and other causes exist.

Can hearing aids or Lenire help pulsatile tinnitus?

They are not the treatment for the cause. Lenire is not for pulsatile tinnitus. A medical workup comes first.

When will U.S. enrollment start?

Sonorous expects it in the fourth quarter of 2026. We could not confirm that enrollment has begun, and we will update this page.

Explore related pages

Keep exploring California Hearing Center

Set up your free hearing consultation

Turn life up with better hearing.

Request an appointment